AMD vs CBRS: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

AMD is the larger of the two ($711.78B market cap): the incumbent the market prices for continued execution (24.38x forward earnings, beta 2.54). CBRS is the smaller challenger ($21.66B), actually pricier on forward earnings (47.97x): more room to run, but more to prove. If you believe in growth, CBRS fits: analysts expect its revenue to rise 215% next year, against 84% for AMD. If you believe in paying less for profit, AMD fits: it trades at 24.38x forward earnings, against 47.97x for CBRS.

AMD vs CBRS: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricAMDCBRSWhat it tells you
Market cap$711.78B$21.66BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E24.3847.97Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Price vs 52-week range51% of range4% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book10.312.36How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: AMD is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how AMD and CBRS affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AMD and CBRS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AMD and CBRS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Advanced Micro Devices (AMD) do?

Advanced Micro Devices (AMD) designs CPUs, GPUs, and adaptive computing chips. The company has two main client-facing CPU lines: Ryzen for consumer PCs and EPYC for data center servers. EPYC has gained significant share against Intel Xeon in cloud and enterprise data centers over the past five years. The Instinct GPU line (MI300X, MI325X, MI350, and the MI400 family including the MI450 and MI455X) is AMD's AI accelerator platform and the primary direct competitor to NVIDIA's data center GPUs, now sold as full Helios rack-scale systems as well as individual chips.

Full AMD guide

What does Cerebras Systems (CBRS) do?

Cerebras Systems (NASDAQ: CBRS) designs AI compute systems built around its Wafer-Scale Engine (WSE), a single chip the size of an entire silicon wafer with roughly 900,000 cores and large on-chip memory. That design keeps whole models in fast on-chip SRAM instead of shuttling weights to and from external memory, which lets Cerebras post very high token-generation speeds for AI inference. The company sells both on-premise systems and cloud inference capacity, positioning itself against Nvidia GPUs for large-model inference and AI supercomputing workloads. Founded in 2015 and based in Sunnyvale, California, it went public in May 2026 in one of the largest semiconductor IPOs on record.

Full CBRS guide

AMD vs CBRS: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • AMD drivers: Instinct AI GPU and Helios rack ramp; EPYC server share gains.
  • CBRS drivers: Inference speed leadership; OpenAI and backlog conversion.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: NVIDIA's structural advantages in AI (CUDA ecosystem, manufacturing capacity allocations from TSMC, customer relationships) make AI GPU share gains harder than the hardware comparison alone suggests. For CBRS, customer concentration is the defining risk: roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers, and much of the future backlog now depends on a single OpenAI agreement, so the loss or renegotiation of one relationship could sharply reduce revenue.

AMD or CBRS: which should you pick?

If the story you believe is AMD's (Instinct AI GPU and Helios rack ramp), AMD is the more direct way to own it; if it is CBRS's (Inference speed leadership), CBRS is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AMD and CBRS guides.

AMD vs CBRS: the full fundamentals

AMD. AMD's trailing P/E of about 92x as of November 20, 2026 looks extreme because GAAP earnings still carry acquisition amortization and have not caught up with the AI order book; on 2027 estimates the multiple is about 24x. The gap between the two is the thesis in numbers: the price assumes revenue roughly doubles to about $96 billion in 2027 on MI450 and Helios shipments, after Q4 2026 guidance of about $17 billion, so any slip in that ramp would show up quickly in a stock that fell about 16.5% in a month on an AI-hardware selloff. The 49 analysts covering it rate it a strong buy with a mean target near $658.

CBRS. As of November 20, 2026, Cerebras trades at roughly 28 times trailing sales and about 47 times 2027 consensus EPS of $1.86, down from about 46 times sales a month earlier as the stock fell faster than revenue grew. The price still rests on converting a backlog reported near $25.4 billion, most tied to OpenAI, into the roughly $2.98 billion of 2027 revenue analysts model. The roughly $7.4 billion cash balance gives the company time to build capacity without new financing.

Headline figures (approximate, November 2026): AMD shows revenue (ttm) ~$45.4 billion (Sept. 2026 quarter up ~45% YoY), gross / operating margin ~56% / ~18% (GAAP, trailing), net income (ttm) ~$7.7 billion (GAAP; higher non-GAAP), eps (ttm) ~$4.68 GAAP; CBRS shows revenue (ttm) ~$756M, revenue growth (q3 2026) ~55% year over year (~$231M), gross / operating margin (ttm) ~30% / ~-99%, net income (ttm) ~-$640M (GAAP).

The bottom line: AMD vs CBRS

AMD and CBRS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined AMD and CBRS exposure against your real portfolio. It is not an investment adviser.

Wondering how AMD or CBRS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Advanced Micro Devices

Ask Walnut's AI anything about AMD and see how it fits what you own.

FAQ

What is the difference between AMD and CBRS?

+

Advanced Micro Devices (AMD) designs CPUs, GPUs, and adaptive computing chips. Cerebras Systems (NASDAQ: CBRS) designs AI compute systems built around its Wafer-Scale Engine (WSE), a single chip the size of an entire silicon wafer with roughly 900,000 cores and large on-chip memory. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is AMD or CBRS the better stock?

+

Neither is universally better. AMD is the larger incumbent; CBRS is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, AMD or CBRS?

+

On forward P/E (as of November 2026), AMD trades at 24.38x and CBRS at 47.97x, so AMD is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both AMD and CBRS?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of AMD vs CBRS?

+

AMD: NVIDIA's structural advantages in AI (CUDA ecosystem, manufacturing capacity allocations from TSMC, customer relationships) make AI GPU share gains harder than the hardware comparison alone suggests. Expectations are now the larger risk: the shares trade near 92x trailing GAAP earnings and about 24x forward, and consensus assumes EPS more than doubles from about $8.08 in 2026 to about $17.64 in 2027 on revenue of roughly $96 billion, which requires the MI450 and Helios ramp to land on schedule. The stock fell from a 52-week high near $659 to about $431 by November 20, 2026, as AMD and Broadcom led a chip-sector decline and AI infrastructure stocks sold off. Free cash flow was only $554 million in the September quarter (a 4% margin) as the company built for the ramp, and the now-closed World Labs deal adds share dilution and integration work. Intel's eventual recovery in server CPUs is a multi-year risk. CBRS: Customer concentration is the defining risk: roughly 86 percent of 2025 revenue came from two UAE-affiliated buyers, and much of the future backlog now depends on a single OpenAI agreement, so the loss or renegotiation of one relationship could sharply reduce revenue. The valuation, a market capitalization near $21.2 billion on about $756 million of trailing revenue (roughly 28 times sales), leaves little margin for execution stumbles or slower AI spending, even after the multiple compressed. Competition is intense, with Nvidia dominant and AMD, Groq, SambaNova, and in-house cloud silicon all pursuing inference. The stock is newly public and highly volatile: it has traded between about $78 and $386 since listing and fell about 53% in the three months to November 20, 2026. Gross margins are modest and have drifted lower, 2025 GAAP profitability was inflated by a one-time non-cash gain rather than operating performance, and GAAP losses in 2026 total roughly $626 million across the first three quarters.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AMD or CBRS; figures are approximate and dated (as of November 2026). Verify current data before investing.